English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Ginseng (Panax ginseng C.A. Mey) is commonly used to treat osteoarthritis (OA) in Chinese traditional medicine (TCM). In this study, we investigated whether ginsenoside retinoblastoma 1 (Rb1), an active component of ginseng, could regulate NO production in chondrocytes and its potential mechanisms of action. SW1353 cells were stimulated with IL-1β in the presence of different concentrations of ginsenoside Rb1. NO concentration was assessed by the Griess reaction. Expression of iNOS, degradation of IBα and nuclear translocation of NF-κB p65 were determined by Western blot. DNA binding activity of NF-κB complex was evaluated with Trans AM™ kit for p65. We found that ginsenoside Rb1 significantly decreased the NO production and iNOS protein expression in a concentration-dependent manner. Ginsenoside Rb1 markedly decreased the IκBα degradation and nuclear p65 levels, as well as inhibited the DNA binding activity of NF-κB complex. These results suggest that ginsenoside Rb1 inhibits IL-1β-induced NO production through downregulation of NF-κB-dependent iNOS expression in chondrocytes, and reveals potential mechanisms explaining the benefits of ginseng for OA treatment in TCM.       Key words: Ginsenoside, retinoblastoma 1 (Rb1), NO, inducible nitric oxide synthase (iNOS), nuclear factor κB (NF-κB), chondrocyte, osteoarthritis.

african journal of pharmacy and pharmacology

Ginsenoside retinoblastoma 1 (Rb1) suppresses NO production and inducible nitric oxide synthase (iNOS) expression by inhibiting nuclear factor B (NF-B) activation in SW1353 chondrosarcoma cells